Market Cap 693.62M P/E - EPS this Y 14.30% Ern Qtrly Grth -
Income -20.71M Forward P/E -37.92 EPS next Y - 50D Avg Chg 14.00%
Sales 27.86M PEG - EPS past 5Y - 200D Avg Chg 63.00%
Dividend N/A Price/Book 13.23 EPS next 5Y - 52W High Chg -25.00%
Recommedations - Quick Ratio 4.71 Shares Outstanding 152.44M 52W Low Chg 727.00%
Insider Own 2.49% ROA -19.87% Shares Float 150.43M Beta -
Inst Own 27.04% ROE -37.39% Shares Shorted/Prior 10.89M/7.50M Price 4.55
Gross Margin 6.45% Profit Margin -74.35% Avg. Volume 4,666,617 Target Price 7.00
Oper. Margin -70.82% Earnings Aug 4 Volume 3,703,977 Change 13.18%
22nd Century Group, Inc. News
09:06 AM 22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference
05/07/21 22nd Century Group (XXII) Q1 2021 Earnings Call Transcript
05/06/21 22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates
05/06/21 22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021
05/05/21 22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production
05/04/21 22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
04/30/21 22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
04/30/21 An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring
04/29/21 Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities
04/26/21 22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
04/22/21 22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results
04/21/21 22nd Century Group Issues Annual Letter to Shareholders
04/20/21 22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
04/15/21 22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
04/08/21 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
04/06/21 3 Best Emerging Marijuana Stocks to Buy in April
04/01/21 Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century
03/23/21 22nd Century Group (NYSEMKT:XXII) Is In A Good Position To Deliver On Growth Plans
03/19/21 Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

XXII Chatroom

User Image Comacho Posted - 53 seconds ago

$XXII hey, Chief; who’s Xavier? And why you dream’n?

User Image HavocSs Posted - 4 minutes ago

$XXII how is fdli and fda connected? If at all

User Image ChiefLittleTurtle Posted - 40 minutes ago

$XXII as I always said. Dips are buying oops on everything you invest in. But you gotta believe in what your investing in before they become a buying opp ! Lol.

User Image InsiderFinance Posted - 43 minutes ago

Top tickers from the Smart Money Unusual Options Activity Daily Recap courtesy of real-time dashboard from 1. RMO 2. CVM 3. GME 4. HGEN 5. FLUX 6. DNMR 7. UXIN 8. FBIZ 9. MARA 10. AMC 11. TSLA 12. PLTR 13. SPCE 14. IQ 15. BIIB 16. $XXII 17. $RUN 18. $ZI 19. $FCEL 20. $YY

User Image investfuture Posted - 46 minutes ago

$XXII @ChiefLittleTurtle thanks for the advice loser

User Image PostBio Posted - 54 minutes ago

$XXII Not a selloff, but simply bid ask spread on very thin volume. @ChiefLittleTurtle

User Image heyvina Posted - 1 hour ago

$XXII like 600 share sell off haha @ChiefLittleTurtle

User Image BCInvestor1 Posted - 1 hour ago

$XXII Fun day, I see $5 clearing tomorrow easily

User Image ChiefLittleTurtle Posted - 1 hour ago

$XXII big sell off after hours. That’s the problem with this company. Blah blah blah. Never any apex. Just rainbow wishes and Xavier dreams.

User Image memestonklord Posted - 1 hour ago

$XXII $PM $MO Your bs products will be banned in a flash! Invest in a company that actually has a clinically proven low nicotine product!

User Image OfficialClownTrader Posted - 1 hour ago

$XXII This stock will make me closer to quit my day job when I hit a million.

User Image memestonklord Posted - 1 hour ago

$XXII $PM $MO You guys are going down! Join a company that is trying to help addiction not create it!

User Image navz Posted - 1 hour ago

$XXII Volume was high, good sign.

User Image joesmith4 Posted - 2 hours ago

$XXII serious question, so this was just announced today ?? The XXII speakers today and tomorrow... What's that about ? Why so hush hush ? Could be something big afoot ? Or not afoot so as to not draw attention Hmmmm

User Image Castle_de_Han Posted - 2 hours ago

$XXII Ya'll my Fiancee is running in her track meet today! Trying to Qualify for the Olympics. Wish her luck please! She got 1K shares of XXII so this is definitely relevant lol

User Image scottmason Posted - 2 hours ago

$XXII IQOS may possibly get baned

User Image leftfork Posted - 2 hours ago

$XXII back to $6 and beyond

User Image milgirl92 Posted - 2 hours ago

$XXII please please let this continue for the entire week…if not I’m gonna start smoking 🥃💊or pill popping or drinking haha

User Image JRshocker Posted - 2 hours ago

$XXII will be a rotation of money flowing into companies with promising IP of genetic sequencing. The manipulation of genetics got us the covid vaccine so quickly investors will be looking at other healthcare/plant research companies with proprietary IP. I think today’s move was with people moving money into cannabis stocks. Not so much the FDLI

User Image smichaels22 Posted - 2 hours ago

$XXII indisputable ta. Line. Go. Up.

User Image PostBio Posted - 2 hours ago

$XXII Collection of useful links for newer shareholders here to get up to speed, or long-term shareholders pump yourself up and give you conviction to HODL. 1. Video by @shivasai777 2. Due Diligence by @Sophisticated_investor2 3. CEO James Mish's letter to Shareholders (April 21, 2021) 4. 2021 Q1 Earnings Call (May 6, 2021)

User Image Tesao67 Posted - 2 hours ago

$XXII Scio me nihil scire...

User Image matttyoc Posted - 2 hours ago

$XXII my Facebook is constantly blowing up about $AMC and @Wallstreet_Bets I comment $XXII on every single post just to throw it out there

User Image StonedHedge1 Posted - 3 hours ago

$XXII Campaign for tobacco free Kids is on the same panel as Pritchard, that would be enlightening to see.

User Image redbeamgold Posted - 3 hours ago

$XXII 2:45 – 3:45 PM | Concurrent Breakout Sessions Center for Food Safety and Applied Nutrition (CFSAN) Session Center for Tobacco Products (CTP) Session During this session, FDA leadership will address the top issues CTP is facing as well as priorities and goals for the coming year. Mitchell R. Zeller, Director, Center for Tobacco Products, FDA Moderated by Dean R. Cirotta, President, EAS Consulting Group and Member, FDLI Board of Directors Center Director Post-Presentation Q&A: CTP Gather with fellow colleagues for a Q&A on issues and topics that were addressed during the Center Director presentation. Mitchell R. Zeller, Director, Center for Tobacco Products, FDA Moderated by Dean R. Cirotta, President, EAS Consulting Group and Member, FDLI Board of Directors anybody hear what was said?

User Image joesmith4 Posted - 3 hours ago

$XXII why does this feel like a bull trap ? Or is things really happening this week, I'm skeptical

User Image joesmith4 Posted - 3 hours ago

$XXII "do you know what a disparity is" "yeah" "Well we don't think we want you going out for hockey" (name that film ?)

User Image RealBaronKarza Posted - 3 hours ago

$XXII me waiting for the market to open tomorrow:

User Image doctrjay Posted - 3 hours ago

$XXII This is what John Pritchard is going to say at the FDLI meeting tomorrow at 3:00 PM

User Image joesmith4 Posted - 3 hours ago

$XXII odd day, yes yes

Analyst Ratings
Chardan Capital Buy Jan 26, 18